PROMETHEUS PROTOCOL

THEEND OF AGING STARTS WITH YOUR CELLS

SCROLL TO EXPAND

Our MissionPioneering the shift from reactive medicine to proactive healthspan optimization

Celljevity is pioneering the shift from reactive medicine to proactive healthspan optimization, using the best of stem cell science, AI, and elite clinical care.

A world where aging is not inevitable decline, but a treatable condition. Where health is personalized, predictive, and preventive.

Learn More

Certified Excellence

GMP Certified Logo
Good Manufacturing Practice
XPRIZE Logo
Healthspan Semi-Finalist
UCLA Logo
Research Partnership
Nature Journal Logo
+others 190+ Publications
GMP Certified Logo
Good Manufacturing Practice
XPRIZE Logo
Healthspan Semi-Finalist
UCLA Logo
Research Partnership
Nature Journal Logo
+others 190+ Publications

The Prometheus ProtocolIn Action

Our revolutionary cellular rejuvenation process combines cutting-edge science with proven clinical results, delivering unprecedented age reversal at the cellular level.

Cellular Rejuvenation

Transform aged cells into youthful, vibrant cells through our proprietary Prometheus Protocol.

Telomere Extension

Achieve unprecedented +32% telomere extension, reversing cellular aging markers to new-born stage.

22-Day Protocol

From initial consultation to cell delivery—our complete rejuvenation process takes approximately 12 weeks.

Multi-System Applications

Comprehensive cellular rejuvenation across skin, joints, cardiovascular, cognitive, immune, and metabolic health.

The Journey to Renewal

Your Rejuvenation Process

From collection to results in six precise steps, each designed to ensure the highest quality and safety standards for your cellular therapy.

1Day 1

Tissue Collection

A small 1cm² skin biopsy is collected from behind the ear under local anesthesia

2Days 2-5

Cell Isolation

Fibroblasts are isolated and expanded in our GMP-certified laboratories

3Days 6-20

Rejuvenation Protocol

Proprietary 15-day treatment reverses cellular aging markers to new-born stage

4Day 21

Quality Validation

Single-cell RNA sequencing confirms successful rejuvenation before release

5Day 22

Therapeutic Delivery

20 billion rejuvenated cells delivered via targeted injection or IV infusion

6Ongoing

Results & Monitoring

Extended telomeres and rejuvenated cellular markers confirmed through comprehensive testing

Our complete rejuvenation process takes approximately 12 weeks from initial consultation to cell delivery

Learn More

The Science Behind Prometheus

Why Epigenetic Reprogramming Works

Aging isn't about worn-out parts—it's about cells that have forgotten how to function. Prometheus Therapy doesn't replace your cells; it updates their operating system.

Based on Dr. Sun's 190+ publications (20,000+ citations) in Nature, Science, and Cell.

Senolytics

Senescent cells accumulate with age, poisoning healthy neighbors. Prometheus Cells identify and eliminate these cellular troublemakers while regenerating tissue.

Epigenetics

DNA methylation patterns control cellular age. Prometheus Therapy resets these patterns—like restoring a vintage car to factory condition without replacing the engine.

Metabolism

Mitochondria lose efficiency with age. Epigenetic reprogramming restores youthful energy production, verified through 32% telomere extension.

Immunology

Aging skews immune responses toward inflammation. Prometheus Cells secrete IL-10 and modulate regulatory T-cells, restoring immune homeostasis.

Explore the Full Science

Global Clinic Network

Temples of Transformation

These are not medical offices. They are sanctuaries where science meets soul, where cutting-edge regenerative medicine is delivered in environments designed for total rejuvenation.

Clinique DelMar Antibes

Antibes, France

Clinique DelMar

Where luxury meets regenerative medicine on the stunning Côte d'Azur. Our flagship facility combines Mediterranean serenity with cutting-edge cellular therapies, offering the complete Prometheus protocol in an environment designed for healing.

Now Open
50+ Patients/Month
FLCHUAE

Coming 2026

Global Expansion

Florida, Switzerland, and UAE. Bringing the Celljevity experience to major cities worldwide, each clinic collecting proprietary data to continuously improve our protocols.

Learn about partnerships
View Clinical Network

Eligibility

Treatment Considerations

The following information is educational only. Consult your physician to determine if these treatments may be appropriate for your individual circumstances.

Prometheus therapy by Celljevity is designed for adults seeking to reverse biological aging, prevent age-related decline, and enhance overall vitality through cutting-edge cellular rejuvenation.

Eligibility & Screening

Who Can Benefit from Prometheus Therapy

Our personalized screening process ensures Prometheus therapy is safe and optimal for each candidate, with eligibility criteria designed to maximize therapeutic outcomes.

Global clinic network and patient presence
16 years

Minimum Age
Patients 16-17 require parental consent and additional medical clearance

40+ years

Optimal Age Range
Greatest therapeutic benefit observed in adults 40+ experiencing early to moderate age-related decline

Required

Comprehensive Screening
All candidates undergo thorough medical evaluation by our integrated care teams to ensure safety and optimal outcomes

The following information is educational only. Consult your physician to determine if these treatments may be appropriate for your individual circumstances.

Treatment Considerations

Adults 40+ with Age-Related Decline

Experiencing reduced vitality, recovery speed, and resilience.

Joint or Mobility Issues

Mild to moderate osteoarthritis or degenerative conditions.

Preventive Longevity Care

Motivated to delay aging and preserve youthfulness.

Autoimmune or Chronic Inflammatory Conditions

Where cellular rejuvenation may offer added support.

Biological Age Reversal

Interested in telomere extension and improved biological markers.

High-Performance Individuals

Executives, athletes, entrepreneurs maintaining peak function.

All treatments are personalized and require eligibility screening. Please consult with your healthcare provider to determine if these treatments may be appropriate for you.

Learn About Eligibility

Request information about eligibility requirements and treatment considerations. Our team can provide educational resources to help you discuss these options with your healthcare provider.

Latest from Our Blog

Research stories, clinical insights, and platform updates

Explore the latest regenerative discoveries, clinic-ready playbooks, and product launch updates from the Celljevity platform.

View all articles
Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies
Press Coverage

Inclusive Healthcare: Celljevity's Mission to Broaden Access to Advanced Therapies

Celljevity's innovative approach to making advanced cellular therapies accessible to broader populations through strategic partnerships and global expansion.

BBN Times
Read
Breakthrough in Cellular Reprogramming: How Celljevity's Prometheus Therapy Reverses Biological Aging
Press Coverage

Breakthrough in Cellular Reprogramming: How Celljevity's Prometheus Therapy Reverses Biological Aging

Revolutionary cellular reprogramming technology shows promising results in reversing biological aging markers and restoring cellular function.

APN News
Read
Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation
Press Coverage

Diederik van der Reijt - Celljevity: Pioneering the Future of Cellular Rejuvenation

CEO Diederik van der Reijt discusses Celljevity's vision for revolutionizing healthcare through cellular therapy and the company's ambitious growth plans.

The Boss Magazine
Read

Our Team

World-Class Leadership

Led by experienced executives and guided by distinguished advisors

Leadership Team

Diederik van der Reijt

Chief Executive Officer

Dr. Yi Eve Sun

Chief Science Officer

Dr. Digvijay Gahtory

Chief Business Officer

Dr. Henk Viëtor

Chief Medical Officer

Dr. Christopher Juel-Jensen

Chief Integration Officer

David Maman

Chief Operational Officer

Dan Fobes

Chief Technology Officer

Karen Brink

Chief Growth Officer

Daniel Erasmus

Chief Artificial Intelligence Architect

Rhys Tombling

Finance Director

Furqan Athar

President MENA Operations

Alexander Berg

Life Sciences Director

Advisory Board

Dr. Lin Quan

Clinical Director, UCLA

Dr. Adeel Khan

Board-Certified Physician

Dr. Henry Delmar

Founder, Clinic Del Mar

Dr. Pierre Maldiney

Cardiologist & Anti-Aging Physician

Dr. Murat Bozkurt

Medical Advisor

Neil Bush

Senior Advisor

Stephen Bradley

Non-Executive Director

Paul Spiegel

Strategic Advisor

Anne Popkin

Strategic Advisor

Jörg Rieker

Strategic Advisor

Dave Bizer

Investment Advisor

Jamie Grooms

Executive Board Member

Shirin Azad

Strategic Advisor

View full team

Questions & Answers

Frequently Asked Questions

Everything you need to know about Prometheus therapy

Can't find what you're looking for? Contact our specialist team

Treatment Process

Clinical & Scientific

Practical Information

Still have questions? Contact our specialist team

Contact Us

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.